GILD vs STEM · P/E 18, rev $29.44B vs rev $144.6M
Gilead Sciences Inc (GILD) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. STEM currently screens at market cap $82.1M.
Not investment advice. Open the GILD and STEM stock pages for the full models.
Not investment advice.